City

Stanford (2)

Columbus (1)

Portland (1)

Tucson (1)

Washington (1)

Condition

Chronic Leukemia (2)

Acute Leukemia (1)

B-cell Leukemia (1)

Chronic Lymphocytic Leukemia (CLL) (1)

Hodgkin's Lymphoma (1)

Leukemia (1)

Multiple Myeloma (1)

Non-Hodgkin's Lymphoma (1)

Waldenstrom's Macroglobulinemia (1)

Overall Status

Completed (2)

Sign in for free

Phase

phase 1 (1)

phase 2 (1)

Sponsor

Steven E. Coutre (1)

Vertex Pharmaceuticals Incorporated (1)

Collaborator

Bayer (1)

Intervention

alemtuzumab (1)

avn-944 capsules for oral administration (1)

cytoxan (1)

fludarabine (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (2)

chronic leukemia

Showing NaN - NaN of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Leukemia, B-cell Leukemia, Chronic Leukemia Trial in Stanford (Alemtuzumab, Fludarabine, Cytoxan)

Completed

Has Results

Leukemia
+3 more

Alemtuzumab
+2 more

Stanford, California

Stanford University School of Medicine

Sep 25, 2014

Acute Leukemia, Chronic Leukemia, Multiple Myeloma Trial in United States (AVN-944 capsules for oral administration)

Completed

Acute Leukemia
+5 more

AVN-944 capsules for oral administration

Tucson, Arizona
+4 more

Aug 2, 2011